Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ P10, Inc. (PX) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Asset Management
$7.55
+0.16 (2.17%)Did PX Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if P10 is one of their latest high-conviction picks.
Based on our analysis of 1 Wall Street analyst, PX has a bullish consensus with a median price target of $15.50 (ranging from $13.00 to $25.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $7.55, the median forecast implies a 105.3% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for PX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 17, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Feb 13, 2026 | Barclays | Overweight | Maintains | $N/A | |
| Nov 7, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Jul 14, 2025 | Oppenheimer | Outperform | Maintains | $N/A | |
| May 13, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| May 9, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Apr 14, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Apr 7, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Feb 13, 2025 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Feb 13, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Jan 13, 2025 | Barclays | Overweight | Maintains | $N/A | |
| Jan 7, 2025 | JP Morgan | Overweight | Upgrade | $N/A | |
| Dec 12, 2024 | Oppenheimer | Outperform | Maintains | $N/A | |
| Dec 9, 2024 | Barclays | Overweight | Maintains | $N/A | |
| Nov 12, 2024 | JP Morgan | Neutral | Maintains | $N/A | |
| Nov 11, 2024 | Stephens & Co. | Overweight | Maintains | $N/A | |
| Nov 11, 2024 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Nov 8, 2024 | Keefe, Bruyette & Woods | Market Perform | Reiterates | $N/A | |
| Aug 21, 2024 | UBS | Neutral | Downgrade | $N/A | |
| Aug 14, 2024 | Morgan Stanley | Equal-Weight | Maintains | $N/A |
The following stocks are similar to P10 based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
P10, Inc. has a market capitalization of $830.61M with a P/E ratio of 81.1x. The company generates $301.31M in trailing twelve-month revenue with a 5.1% profit margin.
Revenue growth is +2.3% quarter-over-quarter, while maintaining an operating margin of +30.3% and return on equity of +4.5%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides private market investment solutions.
The company generates revenue by offering a diverse range of private market solutions, including private equity, venture capital, impact investing, and private credit. It operates through various brands and focuses on primary fund of funds, secondary investments, and direct co-investments, catering to a wide array of investors seeking alternative asset management opportunities.
Founded in 1992, P10, Inc. is headquartered in Dallas, Texas, and operates not only in the United States but also in Dubai, indicating its international presence in the alternative investment landscape.
Financial Services
Asset Management
267
Mr. Luke A. Sarsfield III
United States
2021
Based on our analysis of 1 Wall Street analysts, P10, Inc. (PX) has a median price target of $15.50. The highest price target is $25.00 and the lowest is $13.00.
According to current analyst ratings, PX has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $7.55. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict PX stock could reach $15.50 in the next 12 months. This represents a 105.3% increase from the current price of $7.55. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering a diverse range of private market solutions, including private equity, venture capital, impact investing, and private credit. It operates through various brands and focuses on primary fund of funds, secondary investments, and direct co-investments, catering to a wide array of investors seeking alternative asset management opportunities.
The highest price target for PX is $25.00 from at , which represents a 231.1% increase from the current price of $7.55.
The lowest price target for PX is $13.00 from at , which represents a 72.2% increase from the current price of $7.55.
The overall analyst consensus for PX is bullish. Out of 1 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $15.50.
Stock price projections, including those for P10, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.